These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 19339790)

  • 61. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
    Garcia JM; Polvino WJ
    Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Idiopathic central precocious puberty in 28 boys.
    Pigneur B; Trivin C; Brauner R
    Med Sci Monit; 2008 Jan; 14(1):CR10-14. PubMed ID: 18160938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin sensitivity decreases in short children born small for gestational age treated with growth hormone.
    Bachmann S; Bechtold S; Bonfig W; Putzker S; Buckl M; Schwarz HP
    J Pediatr; 2009 Apr; 154(4):509-13. PubMed ID: 19038401
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
    Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
    Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Growth hormone therapy in short children born small for gestational age.
    Ong K; Beardsall K; de Zegher F
    Early Hum Dev; 2005 Dec; 81(12):973-80. PubMed ID: 16271835
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant.
    Marchisotti FG; Jorge AA; Montenegro LR; Berger K; de Carvalho LR; Mendonca BB; Arnhold IJ
    Growth Horm IGF Res; 2009 Apr; 19(2):179-86. PubMed ID: 19036620
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Growth hormone action in puberty: effects by gender.
    Mauras N; Bishop K; Welch S
    Growth Horm IGF Res; 2007 Dec; 17(6):463-71. PubMed ID: 17566776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
    Ekström K; Salemyr J; Zachrisson I; Carlsson-Skwirut C; Ortqvist E; Bang P
    Diabetes Care; 2007 Jun; 30(6):1357-63. PubMed ID: 17372150
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
    Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
    Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA; Kamp GA; Visser-van Balen H; Mul D; Waelkens JJ; Jansen M; Verhoeven-Wind L; Delemarre-van de Waal HA; de Muinck Keizer-Schrama SM; Leusink G; Roos JC; Wit JM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1402-8. PubMed ID: 17284626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
    Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
    Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Abnormal sex chromosome constitution and longitudinal growth: serum levels of insulin-like growth factor (IGF)-I, IGF binding protein-3, luteinizing hormone, and testosterone in 109 males with 47,XXY, 47,XYY, or sex-determining region of the Y chromosome (SRY)-positive 46,XX karyotypes.
    Aksglaede L; Skakkebaek NE; Juul A
    J Clin Endocrinol Metab; 2008 Jan; 93(1):169-76. PubMed ID: 17940117
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
    Jung H; Land C; Nicolay C; De Schepper J; Blum WF; Schönau E
    Eur J Endocrinol; 2009 Feb; 160(2):149-56. PubMed ID: 19039085
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results.
    Mericq V; Lammoglia JJ; Unanue N; Villaroel C; Hernández MI; Avila A; Iñiguez G; Klein KO
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):686-90. PubMed ID: 19302581
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effects of Chinese herbal medicine on modulating the course of puberty development in children with precocious puberty].
    Cai DP; Chen BY; Zhang W; Li P
    Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):166-74. PubMed ID: 16529694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combined diagnostic value of insulin-like growth factor-1, insulin-like growth factor binding protein-3, and baseline luteinizing hormone levels for central precocious puberty in girls.
    Ouyang L; Yang F
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):874-879. PubMed ID: 35635485
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.
    Lee PA; Klein K; Mauras N; Neely EK; Bloch CA; Larsen L; Mattia-Goldberg C; Chwalisz K
    J Clin Endocrinol Metab; 2012 May; 97(5):1572-80. PubMed ID: 22344198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.